Indian drugmaker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of its U.S. price. Adalimumab was approved globally in 2002 and has been the most preferred drug for patients suffering from auto immune disorders.
The drug's branded version is sold under the name Humira by U.S. firm AbbVie Inc, and costs $1,000 for a vial in the United States. Humira…

This is a caregiver training video resource from HCA Hospice Care, Singapore.
It shows how you can gently massage to soothe an elderly person or a patient.
Changed
09/Apr/2016
Condition